Niagen Bioscience (NAGE) Cash & Equivalents Growth (5y) (2019 - 2026)
Niagen Bioscience (NAGE) Cash & Equivalents Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,824.80 Bn | 1,824.74 Bn | - |
| 2 | Akari Therapeutics | 955.99 Bn | 955.99 Bn | - |
| 3 | BeOne Medicines | 473.90 Bn | 469.11 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.79 Bn | 116.54 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.64 Bn | 62.88 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.78 Bn | 62.78 Bn | - |
| 7 | Argenx Se | 55.45 Bn | 50.27 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 37.16 Bn | 37.16 Bn | - |
| 10 | Niagen Bioscience | 262.93 Mn | 196.38 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.28% |
| Dec 31, 2025 | 31.15% |
| Jun 30, 2025 | 26.20% |
| Mar 31, 2025 | 32.52% |
| Dec 31, 2024 | 18.88% |
| Sep 30, 2024 | 11.41% |
| Jun 30, 2024 | 7.13% |
| Mar 31, 2024 | 7.36% |
| Dec 31, 2023 | 3.86% |
| Sep 30, 2023 | -1.04% |
| Jun 30, 2023 | -4.58% |
| Mar 31, 2023 | -10.83% |
| Dec 31, 2022 | -14.75% |
| Sep 30, 2022 | -11.19% |
| Jun 30, 2022 | 3.84% |
| Mar 31, 2022 | 77.69% |
| Dec 31, 2021 | 76.62% |
| Sep 30, 2021 | 70.99% |
| Jun 30, 2021 | 63.00% |
| Mar 31, 2021 | 71.70% |